Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade.
The company’s stock has a 5-day price change of 5.53% and -6.32% over the past three months. IBRX shares are trading 4.30% year to date (YTD), with the 12-month market performance down to -58.41% lower. It has a 12-month low price of $1.83 and touched a high of $7.63 over the same period. IBRX has an average intraday trading volume of 7.84 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 7.86%, 1.75%, and -21.86% respectively.
Institutional ownership of ImmunityBio Inc (NASDAQ: IBRX) shares accounts for 9.09% of the company’s 853.39M shares outstanding.
It has a market capitalization of $2.36B and a beta (3y monthly) value of 0.03. The earnings-per-share (ttm) stands at -$0.58. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.49% over the week and 7.22% over the month.
Analysts forecast that ImmunityBio Inc (IBRX) will achieve an EPS of -0.1 for the current quarter, -0.11 for the next quarter and -0.27 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.12 while analysts give the company a high EPS estimate of -0.12. Earnings per share for the fiscal year are expected to increase by 23.85%, and 37.73% over the next financial year.
Looking at the support for the IBRX, a number of firms have released research notes about the stock. Piper Sandler stated their Overweight rating for the stock in a research note on May 20, 2025, with the firm’s price target at $5. H.C. Wainwright coverage for the ImmunityBio Inc (IBRX) stock in a research note released on March 06, 2025 offered a Buy rating with a price target of $8. BTIG Research was of a view on January 10, 2025 that the stock is Buy, while Piper Sandler gave the stock Neutral rating on May 12, 2023, issuing a price target of $10- $4. Jefferies on their part issued Buy rating on August 03, 2022.
